GREEN GROWTH BRANDS COMPLETES UPSIZED RAISE OF $85 MILLION TO SATISFY OVERWHELMING INVESTOR DEMAND

Green growth brands mg magazine
Green growth brands mg magazine

Markets eager to back proven blue chip retailers in the evolving cannabis space

Toronto, Ontario, September 25, 2018 – Green Growth Brands Ltd. (“GGB” or the “Company”) is pleased to announce that it has raised C$85 million in a private placement, overachieving on its initial target of C$55 million. Intense interest in the placement led to the increased offering, with over 75 per cent of orders originating from highly sophisticated strategic investors. GGB is now positioned to scale up and compete with established players in the both the North American and international cannabis markets.

The gross proceeds of C$85 million are pursuant to a private placement of unsecured 12 per cent convertible debentures at a price of $1,000 per debenture (the “Ðebentures”) (the “Debenture Financing”).

Advertisement

“We’re extremely pleased with the success of this round of financing,” said Peter Horvath, CEO of Green Growth Brands. “We received significant interest from a number of strategic investors and decided to increase the round to $85 million to bring them on board. This oversubscription confirms investors’ confidence in our story, our brands and our team.”

“The chance to participate in an early-stage cannabis company with global potential was also attractive to investors,” continued Horvath. “While our competitors are mainly focusing only on the U.S. market, our backers were particularly interested in our ability to operate on a global level. That, combined with our strong foundation in the significant and growing U.S. cannabis market, made this a unique opportunity that our investors didn’t want to pass up.”

US$30,347,500 of the net proceeds of the Debenture Financing was loaned to Xanthic Biopharma Inc. (“Xanthic”) pursuant to a loan agreement dated August 30, 2018 among GGB, GGB Nevada LLC (“GGB Nevada”) and Xanthic (the “Loan Agreement”). The balance of the net proceeds remains available to GGB for general corporate and working capital purposes and to finance potential acquisition activity. The Company previously announced that it has entered into an arm’s length business combination agreement (the “Definitive Agreement”) with Xanthic pursuant to which Xanthic and GGB have agreed to combine by way of amalgamation (the “Business Combination”).

Advertisement
Previous articleFive Schools Approved for Cannabis Research in Philly
Next articleAre Cannabis Stocks Overhyped?